Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06173401 · ClinicalTrials.gov registry record · Phase 3
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
A Phase 3 study of Spinal Metastases, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 274
- Enrollment target
- 1
- Study location
NCT06173401: Recruiting Phase 3 study of Spinal Metastases, sponsored by Stanford University.
NCT06173401 is a Phase 3 study of Spinal Metastases that is actively recruiting participants, run by Stanford University. The registered enrollment target is 274 participants, above the 63-participant average among 5 other Spinal Metastases trials with a reported enrollment target (335% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06173401, a Phase 3 study of Spinal Metastases, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 274 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine whether fractionated Stereotactic radiosurgery (SRS) for spine metastases is associated with improved local tumor control compared to single-fraction SRS. Patients will be randomized to treatment with spine SRS using either 22 Gy in 1 fraction or 28 Gy in 2 fractions.
Primary Outcome
To determine whether fractionated Stereotactic Radiosurgery (SRS) for spine metastases is associated with improved local tumor control at 1 year following SRS compared to single-fraction SRS.
Conditions Studied
Interventions
- RADIATION Single-fraction spine SRS
- RADIATION Multi-fraction spine SRS
Study Locations (1)
California
- Stanford University School of Medicine - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2023-12-18 |
| Est. Completion | 2028-12 |
| Phase | Phase 3 |
What NCT06173401 shows while recruiting
NCT06173401 is an interventional study that assigns participants to a tested intervention. The registered 274 participants enrollment target is mid-sized for trials with a published cap, above the 63-participant average among 5 other Spinal Metastases trials with a reported enrollment target (335% higher).
The record links to 1 condition, with Spinal Metastases appearing as the primary indexed condition, and to 2 interventions - of which Single-fraction spine SRS is the first listed.
NCT06173401 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06173401 about?
NCT06173401 is a clinical study titled "Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases". The goal of this study is to determine whether fractionated Stereotactic radiosurgery (SRS) for spine metastases is associated with improved local tumor control compared to single-fraction SRS. Patients will be randomized to treatment with spine SRS using either 22 Gy in 1 fraction or 28 Gy in 2 fra...
What is the current status of trial NCT06173401?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 274 participants. The study started on 2023-12-18. Estimated completion is 2028-12.
What conditions does trial NCT06173401 study?
This clinical trial studies the following conditions: Spinal Metastases.
What interventions are being tested in trial NCT06173401?
The interventions under investigation include: Single-fraction spine SRS (RADIATION), Multi-fraction spine SRS (RADIATION).
Who is sponsoring clinical trial NCT06173401?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06173401 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
D20054;LITT for Spine Tumors
RECRUITING · NA
-
A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy
ACTIVE NOT RECRUITING
-
Validation of Novel Predictive Score for Patients With Spinal Metastases
COMPLETED
-
Intra-arterial Chemotherapy for Spinal Metastases
COMPLETED · Phase 1
-
Stereotactic Body Radiotherapy for Spine Tumors
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
- NCT05952583 · 274 participants
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI